get a key
steadybase-$ company ANIP
account_id none on file
legal_name Ani Pharmaceuticals Inc
ticker ANIP
cik 1023024
domain anipharmaceuticals.com
entry_point_account_id none on file
name ANI Pharmaceuticals Inc.
exchange Nasdaq
sector Health Care
hq Princeton, NJ, United States
calls 2 filings 0 executives 6 family 0
why_nownone on file
calls
Remapping and increasing the number of sales territories led to a meaningful increase in productivity, as the smaller territories allowed all of our reps to spend more time detailing Cortrophin and less time traveling.

Aug 8, 2025 / receipt, needs a key / Nikhil Lalwani, CEO | earnings call 2025-08-08 | transcript 3549a650-7857-45d8-b187-f6d14100264c | chars 5533-5751 | segment 5

I'm traveling today. But just a couple of follow-up questions on topics that they already talked about a little bit.

May 10, 2024 / receipt, needs a key / Vanille Devon, other | earnings call 2024-05-10 | transcript 25e0a658-7167-439a-be81-e889e2ed5a60 | chars 23483-23599 | segment 24

filingsnone on file
executives
Antonio Pera director - receipt
Chris Mutz SVP - receipt
Matt Leonard director - receipt
Nikhil Lalwani CEO - receipt
Stephen Carey Senior Vice President, Finance and Chief Financial Officer linkedin receipt
Thomas J. Haughey Chairman - receipt
familynone on file
upcoming
2026-11-06 earnings call scheduled ir
changes
2025-12-01 Chairman, appointed sec_8k
2023-08-23 director, appointed sec_8k
2020-08-06 director, appointed sec_8k
2020-08-03 President and Chief Executive Officer, appointed sec_8k
2020-04-14 President and Chief Executive Officer, departed sec_8k
mcp_package_hint
steadybase-$